[go: up one dir, main page]

MX2010007578A - Preparacion nutriceutica o farmaceutica revestida con una liberacion acelerada controlada de sustancia activa. - Google Patents

Preparacion nutriceutica o farmaceutica revestida con una liberacion acelerada controlada de sustancia activa.

Info

Publication number
MX2010007578A
MX2010007578A MX2010007578A MX2010007578A MX2010007578A MX 2010007578 A MX2010007578 A MX 2010007578A MX 2010007578 A MX2010007578 A MX 2010007578A MX 2010007578 A MX2010007578 A MX 2010007578A MX 2010007578 A MX2010007578 A MX 2010007578A
Authority
MX
Mexico
Prior art keywords
meth
weight
weight based
acrylic
active substance
Prior art date
Application number
MX2010007578A
Other languages
English (en)
Inventor
Hans-Ulrich Petereit
Hema Ravishankar
Shraddha Bodinge
Original Assignee
Evonik Roehm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm Gmbh filed Critical Evonik Roehm Gmbh
Publication of MX2010007578A publication Critical patent/MX2010007578A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención trata sobre una preparación farmacéutica o nutricéutica que consta de a) un núcleo que contiene una sustancia farmacéutica o nutricéuticamente activa; y b) capa controladora que rodea el núcleo y consta de i) 55 a 92% por peso con base en el peso total de copolímeros (met) acrílicos presentes en la capa de un o una mezcla de una variedad de copolímeros de (met) acrilato compuesta de 80 a 98% por peso con base en el peso del copolímero (met) acrílico de unidades estructurales derivadas del C1 a C4 alquil ésteres del ácido (met) acrílico y 2 a 20% por peso con base en el peso del copolímero (met) acrílico de unidades estructurales derivado de monómeros de (met) acrilato con un grupo de amonio cuaternario en el radical alquilo; y ii) 8 a 45% por peso con base en el peso total de los copolímeros (met) acrílicos presentes en la capa de uno o una mezcla de una variedad de copolímeros de (met) acrilato compuesto por más de 5 a 59% por peso con base en el peso del copolímero o unidades estructurales derivadas del ácido acrílico o del ácido metacrílico, y tabletas o cápsulas que contienen lo mismo.
MX2010007578A 2008-01-10 2008-02-01 Preparacion nutriceutica o farmaceutica revestida con una liberacion acelerada controlada de sustancia activa. MX2010007578A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN94CH2008 2008-01-10
PCT/EP2008/051240 WO2009086942A1 (en) 2008-01-10 2008-02-01 Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release

Publications (1)

Publication Number Publication Date
MX2010007578A true MX2010007578A (es) 2010-08-03

Family

ID=39811828

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010007578A MX2010007578A (es) 2008-01-10 2008-02-01 Preparacion nutriceutica o farmaceutica revestida con una liberacion acelerada controlada de sustancia activa.

Country Status (10)

Country Link
US (1) US20110070302A2 (es)
EP (1) EP2231122A1 (es)
JP (1) JP2011509266A (es)
KR (1) KR20100103565A (es)
CN (1) CN101888832A (es)
BR (1) BRPI0821985A2 (es)
CA (1) CA2711475A1 (es)
IL (1) IL205492A (es)
MX (1) MX2010007578A (es)
WO (1) WO2009086942A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201021186D0 (en) 2010-12-14 2011-01-26 Novabiotics Ltd Composition
KR20240059654A (ko) 2014-12-20 2024-05-07 소노마슈티컬스, 엘엘씨 비알콜성 지방간 질환용 및 다른 용도의 포도 생산물
NL2014348B1 (en) * 2015-02-25 2016-10-13 Univ Delft Tech Controlled release from particles encapsulated by molecular layer deposition.
BR112021017735A2 (pt) * 2019-03-11 2021-11-16 Evonik Operations Gmbh Forma de dosagem que compreende uma matriz polimérica
EP4072532B1 (en) 2019-12-11 2024-01-24 Evonik Operations GmbH Dosage form for use in treating or preventing of a disease

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
ES2077023T3 (es) * 1989-03-10 1995-11-16 Yamanouchi Pharma Co Ltd Material de recubrimiento que controla la liberacion de un medicamento para formulaciones de actividad prolongada.
JPH08143476A (ja) * 1994-11-18 1996-06-04 Japan Tobacco Inc 薬物放出制御膜及び固形製剤
FR2759293B1 (fr) * 1997-02-11 1999-04-30 Ethypharm Lab Prod Ethiques Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
DE10013029A1 (de) * 2000-03-17 2001-09-20 Roehm Gmbh Mehrschichtige Arzneiform für die Colonfreigabe
HUP0401941A3 (en) * 2001-07-16 2008-04-28 Astrazeneca Ab Pharmaceutical formulation comprising a proton pomp inhibitor and antacids and process for its preparation
MXPA04010956A (es) * 2003-01-30 2005-01-25 Roehm Gmbh Forma de dosis farmaceutica y metodo para la produccion de la misma.
EP1677766B1 (de) * 2003-10-31 2012-03-14 Hexal AG Pharmazeutische wirkstoffhaltige formulierung mit überzug
DE10353196A1 (de) * 2003-11-13 2005-06-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform mit einer die Abgabe einer modulatorischen Substanz beeinflussenden Matrix
DE10353186A1 (de) * 2003-11-13 2005-06-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform, enthaltend eine in Bezug auf die Wirkstoffabgabe modulatorisch wirkende Substanz
GB0403098D0 (en) * 2004-02-12 2004-03-17 Euro Celtique Sa Extrusion
PL2051704T3 (pl) * 2006-08-18 2012-09-28 Evonik Roehm Gmbh Kompozycja farmaceutyczna o kontrolowanym dostarczaniu substancji aktywnej o dobrej rozpuszczalności
RU2434630C2 (ru) * 2006-08-31 2011-11-27 Юранд, Инк. Системы доставки лекарственных средств, включающие в себя твердые растворы слабоосновных лекарственных средств
DE102007009243A1 (de) * 2007-02-22 2008-09-18 Evonik Röhm Gmbh Pellets mit einer Wirkstoff-Matrix und einem Polymerüberzug, sowie ein Verfahren zur Herstellung der Pellets

Also Published As

Publication number Publication date
CA2711475A1 (en) 2009-07-16
US20100255092A1 (en) 2010-10-07
WO2009086942A1 (en) 2009-07-16
JP2011509266A (ja) 2011-03-24
IL205492A0 (en) 2010-12-30
KR20100103565A (ko) 2010-09-27
US20110070302A2 (en) 2011-03-24
EP2231122A1 (en) 2010-09-29
BRPI0821985A2 (pt) 2015-06-23
CN101888832A (zh) 2010-11-17
IL205492A (en) 2014-07-31

Similar Documents

Publication Publication Date Title
WO2007006353A3 (de) Verwendung eines teilneutralisierten, anionischen (meth) acrylat-copolymers als uberzug fur die herstellung einer arzneiform mit einer wirkstofffreisetzung bei erniedrigten ph-werten
MX2013014142A (es) Composicion farmaceutica o nutraceutica de resistencia gastrica con resistencia contra la influenza de etanol.
IL195407A0 (en) Pharmaceutical composition with controlled active ingredient delivery for active ingredients with good solubility in water
UA103844C2 (ru) Фармацевтический состав, который содержит в матрице, которая подвергается эрозии, один или более эфиров фумаровой кислоты
MX369648B (es) Poli (met) acrilato basados en microcapsulas que contienen feromonas.
IL167334A (en) Multilayer dosage forms which contain active substances and which comprise a neutral core and an inner and outer coating consisting of methacrylate copolymers and methacrylate monomers
WO2005046649A3 (de) Mehrschichtige arzneiform, enthaltend eine in bezug auf die wirkstoffreigabe modularisch wirkende substanz
WO2000019984A3 (de) Überzogene arzneiformen mit kontrollierter wirkstoffabgabe
MX2010007579A (es) Preparacion nutriceutica o farmaceutica revestida con una liberacion de sustancia activa de impulsion mejorada.
MX2010007578A (es) Preparacion nutriceutica o farmaceutica revestida con una liberacion acelerada controlada de sustancia activa.
IL180849A (en) Medicament in a multilayer form
RU2014101227A (ru) Композиция покрытия, подходящая для фармацевтических или нутрицевтических лекарственных форм
EP2492330A3 (en) Removable Water-Dispersible Acrylic Pressure-Sensitive Adhesive Composition and Pressure-Sensitive Adhesive Sheet
ES2720952T3 (es) Composiciones adhesivas transdérmicas, dispositivos y métodos
WO2013095993A3 (en) Water resistant personal care polymers
MX376383B (es) Composicion farmaceutica o nutraceutica con resistencia contra la influencia del etanol
MX2015010449A (es) Composicion farmaceutica multiparticulada que comprende una multitud de dos clases de granulos.
WO2005079748A3 (en) Pharmaceutical preparation for sustained release of a pharmaceutically active ingredient
RU2012140651A (ru) Фармацевтический или нутрицевтический состав
UA93530C2 (ru) Композиция c пролонгированным высвобождением активного вещества, способ ee получения и применения
MX344482B (es) Adhesivos estructurales, proceso para su preparacion y su aplicacion.
WO2008115961A3 (en) Sustained-release composition
MX2021010914A (es) Forma de dosificacion que comprende una matriz polimerica.